PTC Therapeutics Inc

PTCT

Company Profile

  • Business description

    PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The company views its operations and manages its business in one operating segment: life science, which is focused on the discovery, development and commercialization of the company's clinically differentiated medicines that provide benefits to patients with rare disorders.

  • Contact

    500 Warren Corporate Center Drive
    WarrenNJ07059
    USA

    T: +1 908 222-7000

    E: [email protected]

    https://www.ptcbio.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2026

    Employees

    991

Stocks News & Analysis

stocks

Oracle earnings: Solid execution secures revenue target and mitigates investor concerns

We raise our fair value estimate for Oracle stock.
stocks

US dividend shares are getting a boost from the HALO trade. Can it last?

Both high-dividend stocks and dividend-growth stocks are outperforming amid AI disruption.
stocks

Unconventional wisdom: A modern day bank run

Is the economy and investor portfolios at risk from a potential ‘bank run’ in private credit?

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,839.1026.300.30%
CAC 407,911.5372.91-0.91%
DAX 4023,447.29142.36-0.60%
Dow JONES (US)46,558.47119.38-0.26%
FTSE 10010,261.1544.00-0.43%
HKSE25,465.60251.16-0.98%
NASDAQ22,105.36206.62-0.93%
Nikkei 22553,819.61633.35-1.16%
NZX 50 Index13,187.3411.95-0.09%
S&P 5006,632.1940.43-0.61%
S&P/ASX 2008,617.1029.200.34%
SSE Composite Index4,095.4533.65-0.82%

Market Movers